286 related articles for article (PubMed ID: 21711262)
1. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
Raspotnig M; Vedeler CA; Storstein A
Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
[TBL] [Abstract][Full Text] [Related]
2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
3. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
4. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
6. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
7. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
9. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
11. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
13. Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P; Maddison P
Pract Neurol; 2010 Oct; 10(5):260-70. PubMed ID: 20858627
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
16. Onconeural antibodies in sera from patients with various types of tumours.
Monstad SE; Knudsen A; Salvesen HB; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2009 Nov; 58(11):1795-800. PubMed ID: 19294382
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
18. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
19. Republished: Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P; Maddison P
Postgrad Med J; 2011 Jan; 87(1023):60-70. PubMed ID: 21173051
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neurological syndromes: diagnosis and treatment.
Graus F; Dalmau J
Curr Opin Neurol; 2007 Dec; 20(6):732-7. PubMed ID: 17992098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]